Search Blog
Categories
September 2017
M T W T F S S
« Aug    
 123
45678910
11121314151617
18192021222324
252627282930  

Tags

Valens Groworks Announces Strategic Collaboration

Vancouver, British Columbia–(Newsfile Corp. – September 22, 2017) – Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens“) and its wholly-owned subsidiary Supra THC Services Inc. (“Supra“) are pleased to announce a collaboration between Supra and Thermo Fisher Scientific (Mississauga) Inc. to develop a “Centre of Excellence in Plant Based Medicine Analytics” centered in Kelowna, British Columbia. This agreement is the first of its kind between a Canadian cannabis company and a world leader in Health Science services, with an ability to deliver innovative technologies, purchasing convenience and comprehensive services to this emerging market.

Supra’s operations are located in the Company’s state-of-the-art 17,000 sq ft Kelowna facility, currently undergoing modifications ahead of a significant expansion. Supra will utilize a suite of Thermo Fisher Scientific sector-leading advanced analytical instrumentation to provide analytical services, research and development, forensic analysis and support for clinical trials as well as being a demonstration and training site for Thermo Fisher Scientific clients and third parties involved in this rapidly evolving sector. It will also be used as a regional resource center for universities and companies.

Dr. Rob O’Brien, CEO and Chief Science Officer of Supra THC Services Inc. stated; “There are many plants such as Cannabis that contain active ingredients which could be effective treatments for disease or provide critical health improvements. However, conducting proper clinical trials with materials that contain many active ingredients is challenging, particularly if the effective absorbed dose can vary significantly depending on how the material is consumed. For example, the effectiveness of absorption of active ingredients contained in an oil carrier is much different if that oil is placed under the patients tongue, then if the oil, or edible, is swallowed. To measure the amount of active ingredients and metabolites in blood, urine, hair and saliva, advanced instrumentation and a team of highly qualified personal is essential. With the Supra THC Services team and advanced instrumentation from Thermo Fisher Scientific, many significant advances are expected.”

Luc Dionne, Canadian Sales Manager with Thermo Fisher Scientific (Mississauga) Inc., states We welcome the opportunity to work with Dr. Rob O’Brien and the Supra THC Services team, an organization that conducts testing activities in plant based medicine. Dr. O’Brien has an extensive background in analytical chemistry and is a recognized authority in scientific circles. Dr. O’Brien has worked closely with Thermo Fisher Scientific in the past using several of our market leading technologies to successfully perform testing on natural products, pharmaceutical formulations and environmental samples. We are delighted that his team has selected Thermo Fisher Scientific‘s cost effective analytical testing solutions to promote the advancement of testing protocols to meet the rigorous and regulatory requirements of this market segment.

About Valens GroWorks Corp.

Valens GroWorks Corp. is a CSE-listed company with an aggressive buildout strategy in progress. The Company seeks to capture a broad spectrum of medical cannabis users and adult recreational users once legalized, as well as clinical trial and R&D clients, in pursuit of its ambitious seed-to-sale and farm-to-pharma objectives. The Company also provides management, consulting, testing and support services to domestic and international licensees, as well as financing and managing buildouts of fully-licensed 3rd party operations.

The Company has two wholly-owned subsidiaries based in the Okanagan Valley of British Columbia: 1) Valens Agritech Ltd. (“VAL”) which holds a Health Canada Dealer’s License, and 2) Supra THC Services Inc., a Health Canada licensed cannabis testing lab providing sector-leading analytical and proprietary services to Licensed Producers and ACMPR patients. For more information, please visit http:/valensgroworks.com, http://www.valensagritech.com and http://www.suprathc.ca.

About Thermo Fisher Scientific (Mississauga) Inc.

Thermo Fisher Scientific (Mississauga) Inc. is a wholly owned subsidiary of Thermo Fisher Scientific Inc. (NYSE: TMO) the world leader in serving science, with revenues of more than US$20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands — Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services — we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.

On behalf of the Board of Directors,

VALENS GROWORKS CORP.
(signed) Tyler Robson
Chief Executive Officer

For further information, please contact:

Greg Patchell
Telephone: +1.250.860.8634

Notice regarding Forward Looking Statements

This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.

Opawica Explorations Inc. Cancels Private Placement and Demobilizes Drill Program at Bazooka Property, Quebec

Vancouver, British Columbia–(Newsfile Corp. – September 22, 2017) – Opawica Explorations Inc. (TSXV: OPW) (the “Company”) announces that the proposed private placement (the “Offering”) announced on August 15, 2017 and September 11, 2017 will not proceed at this time due to an abatement of interest stemming from declining gold prices, related weakness in the junior resource sector, and the Company’s current share structure.

In the absence of the Offering, the Company has demobilized its drill program at the Bazooka property, near Rouyn-Noranda, Quebec, that it announced on August 15, 2017. The proposed drill program will not proceed at this time.

There is significant activity in the immediate area of Opawica’s Bazooka property. Richmont Mines Inc. announced on September 11, 2017 that it is selling its Wasamac gold property, situated on Opawica’s north western border, to Monarques Gold Corporation. On September 17, 2017, Yorbeau Resources Inc. (“Yorbeau”) announced that Kinross Gold Corporation (“Kinross”) has completed over 24,000 metres of drilling on the Rouyn Property that is optioned by Kinross. The Rouyn Property is contiguous to the eastern border of Opawica’s Bazooka property and the Company’s McWatters property adjoins the eastern border of Yorbeau’s Rouyn property and Granada Gold Mines Inc.’s land holdings.

The Company believes that the Bazooka and McWatters properties are excellent exploration prospects and are well positioned, covering about seven kilometres of the Cadillac Larder Lake Break.

FOR FURTHER INFORMATION CONTACT:

Paul Antoniazzi
Managing Director
Opawica Explorations Inc.
Telephone: 604-681-3170
Fax: 604-681-3552

Neither the TSX Venture Exchange nor its Regulation Service Provider (as the term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of accuracy of this news release.

Forward-looking Statements

Certain statements in this press release relating to the Company’s exploration activities, project expenditures and business plans are approximate and are “forward-looking statements” within the meaning of securities legislation. The Company does not intend, and does not assume any obligation, to update these forward-looking statements. These forward looking statements represent management’s best judgment based on current facts and assumptions that management considers reasonable, including that operating and capital plans will not be disrupted by issues such as adverse market conditions, mechanical failure, unavailability of parts, labor disturbances, interruption in transportation or utilities, or adverse weather conditions, that there are no material unanticipated variations in budgeted costs, that contractors will complete projects according to schedule, and that actual mineralization on properties may not achieve any category of resource(s). The Company makes no representation that reasonable business people in possession of the same information would reach the same conclusions. Forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. In particular, fluctuations in the price of gold, equity markets or in currency markets could prevent the Company from achieving its targets. Readers should not place undue reliance on forward-looking statements. There is no guarantee that drill results reported in this news release or future releases will lead to the identification of a deposit that can be mined economically, and further work is required to identify resources and reserves. We seek safe harbour.

Lexaria Announces Upcoming Public Events and Warrant Exercise

By Lexaria Bioscience Corp.

KELOWNA, BC / ACCESSWIRE / September 22, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces it will be attending and delivering a presentation at the upcoming Canadian Securities Exchange sponsored “Cannabis in the Capital Markets” event on September 27, in Kelowna, British Columbia. Also presenting at the event will be Dr. Philip Ainsle, Co-Director of the Centre for Heart, Lung and Vascular Health, UBC Okanagan Campus, Kelowna, Canada, who will be Principal Investigator of the previously announce clinical study to be conducted by UBC and Lexaria. More information on the event can be found here.

Lexaria will also be attending and speaking at the Southwest Cannabis Conference and Expo in Phoenix, AZ on October 13 and 14. This B2B event is expected to attract thousands of attendees and more information can be found here.

Separately, Lexaria announced it has received US$93,750 from the exercise of warrants previously granted. The stock warrants were exercised at the price of US$0.15, for a total of 625,000 common shares being issued. The warrants are being exercised by a third party who is neither an officer nor director of the Company.

Following issuance of these common shares, Lexaria will have 68,600,761 common shares issued and outstanding. No commissions or placement fees have been paid related to the funds received from these warrants exercised. Proceeds will be used for general corporate purposes.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

For regular updates, connect with Lexaria:

FOR FURTHER INFORMATION, PLEASE CONTACT:

Lexaria Bioscience Corp.
Alex Blanchard, Communications Manager
(778) 796-1897

Or

NetworkNewsWire (NNW)
www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. There is no assurance that any planned corporate activity, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria Energy Foods, Ambarii, and ViPova™ products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

SOURCE: Lexaria Bioscience Corp.

ReleaseID: 476111

IIROC Trade Halt – Mukuba Resources Limited

Vancouver, British Columbia–(Newsfile Corp. – September 22, 2017) – The following issues have been halted by IIROC:

Company:

Mukuba Resources Limited

TSX-V Symbol:

MKU.H

Reason:

At the Request of the Company Pending News

Halt Time (ET)

14:21

IIROC can make a decision to impose a temporary suspension of trading in a security of a publicly listed company, usually in anticipation of a material news announcement by the company. Trading halts are issued based on the principle that all investors should have the same timely access to important company information. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

– 30 –

For further information: IIROC Inquiries 1-877-442-4322 (Option 3) – Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.

Standard Lithium Ltd., Modern Technology For Lithium Processing, CEO Clip Video

Vancouver, British Columbia–(Newsfile Corp. – September 22, 2017) – Robert Mintak, CEO of Standard Lithium Ltd., speaks on the company’s portfolio of US lithium brine projects.

If you cannot view the video above, please visit:
http://www.b-tv.com/standard-lithium-ceo-clip-90sec/

Standard Lithium Inc. is being featured on CBC’s Documentary Channel Sept. 25— Oct. 8, 2017 Monday through Friday, throughout the day and evenings.

Standard Lithium Inc. (TSXV: SLL):

The world’s demand for lithium is projected to be a whopping 534,000 metric tonnes by 2025. That represents a 300% increase from today. Standard Lithium’s value creation strategy encompasses acquiring a diverse and highly prospective portfolio of domestic production locations led by an innovation & results oriented management team with a strong focus on technical skills.

www.standardlithium.com

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in the US and Canada. These 90 second video profiles broadcast on national TV and are distributed online on top financial portals including: Thomson Reuters, BNN.ca, and Stockhouse.com. They are also disseminated via a video news release to several financial portals including Globe Investor, OTC Markets, TMX Money, and The National Post.

BTV — Business Television/CEO Clip Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com

Stonegate Capital Partners Updates Coverage on Deep Down, Inc. (DPDW)

By Stonegate Capital Partners

DALLAS, TX / ACCESSWIRE / September 22, 2017 / Deep Down, Inc. (OTCQX: DPDW):

Company Description

Deep Down, Inc. (OTCQX: DPDW) is an oilfield services company specializing in complex deepwater and ultra-deepwater oil production, distribution system, and support services. Its services and technological solutions include providing distribution with installation support, engineering services, umbilical terminations, loose-tube steel flying leads, ROVs, and related services along with marine automation, monitoring and control systems, and the design and fabrication of large onshore and offshore carousel systems. It also supports subsea installation, commissioning, and maintenance projects through specialized, highly experienced service teams and engineered technological solutions.

Summary

Deep Down, Inc. provides innovative concepts of subsea distribution systems with specialization in engineering services, installation management, custom fabrication, site integration testing, and inspection and repair of equipment for the subsea oil and gas industry.

  • The Company focuses on complex ultra-deepwater oil production support services and products. Importantly, Deep Down is focused on supporting clients on the completion side vs. drilling.
  • Deep Down provides support for subsea engineering, installation, and maintenance projects through specialized, highly experienced service teams and engineered technological solutions. We note that the Company is more service-oriented, but also produces some specialized products such as steel flying leads.
  • One of DPDW’s core competencies is its ability to collaborate with oil and gas operators, installation contractors and subsea equipment manufacturers to determine the fastest, safest, and most cost-effective solutions to the full spectrum of complex issues that arise in the Company’s industry.
  • While the Company has a diversified base of customers that include operators, installation contractors, and original equipment manufacturers (OEMs), Deep Down has recently made significant inroads with majors.
  • Global spending on subsea production systems is due to reach $65B between 2015 and 2020, a 56% increase from the previous period.
  • The Company reported a backlog of approximately $11M as of Q217, and, while management has discussed a reduction in backlog from historic highs, DPDW continued to report one of its strongest balance sheets at 6/30/17 and also increasing interest in services for non-oil and gas applications, such as the development of deepwater technologies for other industries.
  • Deep Down is focused on margin improvement. For Q217, the Company reported gross margins of approximately 50%, and in Q216 it was 33%. The Company believes it can continue these improved gross margins longer-term.
  • In early 2016, the Company sold its manufacturing facility in Channelview, TX, for $3.8M, allowing DPDW to pay off its only debt of $2.7M and significantly strengthening its balance sheet. Additionally, due to the sale of Channelview and improved efficiency in its remaining facility, the Company has been seeing cost savings of~$35K to $45K/month.
  • Significant upside exists if DPDW can sell or rent two umbilical carousels currently being stored. Expected sale proceeds could generate several million in profit. Alternatively, long-term rental income on a carousel could be significant with high gross margins.

We employ a scenario analysis using multiple relative valuation frameworks. The details are on page 8, and all scenarios show upside. We also note that the current market capitalization of approximately $13.9M is significantly less than the Company’s tangible net worth of $23.4M, with $7.2M in cash on its balance sheet as of Q217.

The full report can be accessed by clicking on the following link:

http://stonegateinc.com/reports/DPDW_SEPT_2017_Final.pdf

About Stonegate Capital Partners

Stonegate Capital Partners is a Dallas-based corporate advisory firm dedicated to serving the specialized needs of small-cap public companies. Since our inception, our mission has been to find innovative, undervalued public companies for our network of leading institutional investors who seek high quality investment opportunities.

SOURCE: Stonegate Capital Partners

ReleaseID: 476109

Pharmaceutical Company Paying Penalty for Misleading Investors About Sales Metric

Washington D.C.–(Newsfile Corp. – September 22, 2017) – The Securities and Exchange Commission today filed fraud charges against a Massachusetts-based biopharmaceutical company that exaggerated how many new patients actually filled prescriptions for an expensive drug that was its sole source of revenue.

Aegerion Pharmaceuticals, now a subsidiary of Novelion Therapeutics, has agreed to pay a $4.1 million penalty to settle the charges that it misled investors on multiple occasions in 2013. The SEC’s complaint alleges that Aegerion told investors that the number of unfilled prescriptions for Juxtapid was not material and the “vast majority” of patients receiving prescriptions ultimately purchased the drug. The SEC alleges that Aegerion’s records reflect that it was actually around 50 percent of prescriptions that resulted in actual drug purchases.

“By no one’s math is 50 percent a vast majority,” said Paul Levenson, Director of the SEC’s Boston Regional Office. “When companies publicly discuss their financial data, they must be truthful. Whether they supply hard numbers or give broader descriptions, they cannot mislead investors.”

According to the SEC’s complaint, Juxtapid is used to treat a rare and potentially life-threatening genetic condition that causes extremely high cholesterol. In 2013 and 2014, it was priced at approximately $250,000 to $300,000 annually per patient. Following Juxtapid’s introduction in 2013, investors and investment analysts had little financial data to estimate Aegerion’s future revenues from sales of the drug.

Aegerion allegedly provided details on the number of Juxtapid prescriptions during several subsequent earnings calls, but this data alone was insufficient for analysts and investors trying to forecast the company’s future revenues because only prescriptions that were actually filled “converted” into sales. According to the SEC’s complaint, it wasn’t until October 2014 that Aegerion disclosed to investors that the conversion rate was actually in the range of 50 to 60 percent. But Aegerion allegedly failed to reveal to investors even then that the conversion rate had hovered around 50 percent since 2013.

The SEC’s complaint, filed in federal court in Boston, charges Aegerion with violating Sections 17(a)(2) and (3) of the Securities Act of 1933. Aegerion agreed to the settlement without admitting or denying the allegations. The settlement is subject to court approval.

The SEC’s investigation, which is continuing, is being conducted by Emily R. Holness, Dawn A. Edick, Ruth Anne Heselbarth, Rachel Hershfang, Marc Jones, and Amy Gwiazda of the Boston office. The SEC appreciates the assistance of the Federal Bureau of Investigation.

Pomerantz LLP and Levi & Korsinsky, LLP Announce Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of TCP International Holdings, Ltd. – TCPIF

By Pomerantz LLP

NEW YORK, NY / ACCESSWIRE / September 22, 2017 / Pomerantz LLP and Levi & Korsinsky, LLP announce that the United States District Court for the Northern District of Ohio has approved the following announcement of a proposed class action settlement that would benefit purchasers of common stock of TCP International Holdings, Ltd. (OTC PINK: TCPIF):

SUMMARY NOTICE OF PENDENCY OF CLASS ACTION AND PROPOSED SETTLEMENT, SETTLEMENT FAIRNESS HEARING, AND MOTION FOR AWARD OF ATTORNEYS’ FEES AND REIMBURSEMENT OF LITIGATION EXPENSES

TO: All Persons who purchased or otherwise acquired TCP International Holdings Ltd. (“TCPI”) common stock (ticker symbol: TCPI) on the public market between May 9, 2015 and November 5, 2015 (the “Class Period”), inclusive, and were damaged thereby.

EXCLUDED FROM THE CLASS ARE DEFENDANTS, THE OFFICERS AND DIRECTORS OF TCPI, AND THEIR FAMILIES AND AFFILIATES.

YOU ARE HEREBY NOTIFIED, pursuant to Rule 23 of the Federal Rules of Civil Procedure and an Order of the United States District Court for the Northern District of Ohio, that a hearing will be held on February 1, 2018 at 10:00 a.m., before the Honorable Donald C. Nugent, United States District Judge, in Courtroom 15A of the United States District Court for the Northern District of Ohio, Carl B. Stokes United States Court House, 801 West Superior Avenue, Cleveland, Ohio, to determine: (1) whether a Settlement Class should be certified for purposes of the Settlement and whether Lead Plaintiff and its counsel have adequately represented the Class Members; (2) whether the proposed Settlement of the Class’s claims against the Defendants for $1,100,000.00 should be approved as fair, reasonable and adequate; (3) whether the proposed Plan of Allocation is fair, just, reasonable, and adequate; (4) whether the Court should permanently enjoin the assertion of any claims that arise from or relate to the subject matter of the Action; (5) whether the Action should be dismissed with prejudice against the Defendants as set forth in the Stipulation of Settlement filed with the Court; (6) whether the application by Lead Counsel for an award of attorneys’ fees and expenses should be approved; and (7) whether an application for reimbursement of costs and expenses of Lead Plaintiff members should be granted.

If you purchased or otherwise acquired TCPI common stock trading under ticker symbol TCPI during the Class Period, your rights may be affected by this Action and the Settlement thereof. You may obtain a detailed Notice of Pendency of Class Action and Proposed Settlement, Settlement Fairness Hearing, and Motion for Award of Attorneys’ Fees and Reimbursement of Litigation Expenses (the “Notice”) and Proof of Claim and Release Form, free of charge by contacting the Claims Administrator, by mail at: TCP Int’l Litigation, c/o Strategic Claims Services, P.O. Box 230, 600 N. Jackson Street, Suite 3, Media, PA 19063; by telephone at: 866-274-4004; or by visiting the website at: www.strategicclaims.net/TCP.

If you are a member of the Class and wish to share in the Settlement money, you must submit a Proof of Claim postmarked no later than March 5, 2018 establishing that you are entitled to recovery. As further described in the Notice, you will be bound by any judgment entered in the Action, regardless of whether you submit a Proof of Claim, unless you exclude yourself from the Class, in accordance with the procedures set forth in the Notice, postmarked by no later than January 12, 2018. Any objections to the Settlement, Plan of Allocation or attorney’s fees and expenses must be filed, in accordance with the procedures set forth in the Notice, to be received no later than January 12, 2018.

Inquiries, other than requests for the Notice, may be made to Lead Counsel for the Class: Leigh Handelman Smollar, Pomerantz LLP, 10 South La Salle Street, Ste. 3505, Chicago, IL 60603, Telephone: 312-377-1181.

INQUIRIES SHOULD NOT BE DIRECTED TO THE COURT, THE
CLERK’S OFFICE, THE DEFENDANTS, OR DEFENDANTS’ COUNSEL

DATED: JULY 28, 2017 BY ORDER OF THE UNITED STATES

DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP

ReleaseID: 476102

PEO Company to Hold Fall Supervisory Boot Camp in October

By Landrum HR

PENSACOLA, FL / ACCESSWIRE / September 22, 2017 / LandrumHR, a professional employer organization (PEO) based in Pensacola, FL, has announced that they will be holding their Fall Supervisory Boot Camp in October 2017. The event consists of two half-day sessions, running from 8:30 a.m. to 12:30 p.m. The first will take place on Wednesday, October 18, and the second the following Wednesday, the 25th. Both sessions will be held at the LandrumHR headquarters on 6723 Plantation Road, Pensacola, FL. Those interested can sign up for the event here.

The Boot Camp training, taught by HR Professional Becki Haines, PHR, SHRM-CP is designed to give supervisors the essential knowledge needed to lead others in the workplace with confidence. Over the course of two days, participants will earn their stars while they explore basic employment laws and learn what compliance of those laws look like from a practical stand point. This training will also cover how to promote a harassment free work environment, tips on interviewing and hiring, coaching employees to success and the proper use of progressive discipline.

As can be seen by those who view their Facebook page, LandrumHR is highly respected by its many clients and seminar participants. “LandrumHR’s Supervisory Boot Camp provided an affordable and enjoyable option for a complete overview of relevant topics supervisors tackle each day. The presentation captured my attention and ignited me to implement a plan for immediate improvements in my company’s HR policies and procedures.”

Those looking to have a place at the upcoming boot camp are encouraged to register as soon as possible as spaces are limited and going quickly.

LandrumHR is a full-service human resources service organization offering staffing, consulting and professional employer services. The company has 175 employees, six office locations with clients and “work-site employees” in 48 states. The company is a recipient of the Florida Governor’s Sterling Award, recognized for their performance excellence. Those interested in learning more about services offered can contact the company here.

Contact Landrum:

Becki Haines
(850) 266-6177
bhaines@landrumhr.com
Landrum HR
6723 Plantation Road
Pensacola, FL 32504

SOURCE: Landrum HR

ReleaseID: 476105

SwitzerCultCreative Represents Jay Miron Furniture

Unique pieces and artistic juxtaposition are inspiration anchors of this partnership

VANCOUVER, BC, September 22, 2017 /24-7PressRelease/ — SwitzerCultCreative now officially represents Jay Miron Furniture. Miron, a retired Canadian BMX athlete who holds multiple world championship and X Games titles and former owner of MacNeil Bikes has made the transition into a new career, designing and building unique furniture pieces.

SwitzerCultCreative’s Partner and Showroom Manager, Adam Bellas said, “It’s an honour to represent Jay Miron’s pieces. His eye for creating unique design combined with his exceptional quality of work sets the bar high. Having his experience as an athlete shows in the passion he demonstrates for his craft.”

Miron’s athletic past has been legendary. In his seventeen-year professional career he won six world championship titles, nine X Games medals and he invented over thirty unique moves including the first ever double back flip on a bicycle. His inspired action has shown through his artistic expression as he works with materials with the same passion and precision that he had shown on the bike. The juxtaposition of art meets creativity with a dose of technique makes his furniture offerings unique. Recently, it has been confirmed that BMX Freestyle will be a sport in the 2020 Olympic Games in Tokyo.

“I’m super excited to be working with SwitzerCultCreative. Their commitment to quality and their focus on representing high-level designers and craftsmen align perfectly with my goals and the furniture I produce. I’m looking forward to a long and successful partnership.” – Jay Miron

The Orca Chair from Miron’s debut collection will be on display at the upcoming IDS Vancouver from September 28 to October 1.

About SwitzerCultCreative : The SwitzerCultCreative mission is the discovery, promotion, marketing and development of modern, original designs for living.

Through our extensive network of designer showrooms in Canada and the United States we provide the opportunity for a carefully curated grouping of original designer Brands to increase brand recognition and develop their market.

In our new Vancouver Showroom and Gallery we are passionate about showcasing both established Brands and new innovative collections of furniture, lighting, accessories and textiles. Our vision for our flagship showroom is to provide the opportunity for designer Brands new to Vancouver and western Canada to flourish and grow.

Our client services team under the leadership of Adam Bellas places the highest value on customer focused relationships where the satisfaction of our clients is the highest priority.

We strive to offer a carefully curated grouping of home furnishings that are of high quality, authentic design in a friendly and fun atmosphere.

In the same way that we care about the food we eat, who grows it and whether it is organic or not, we place the highest importance on knowing every detail of the products we promote.

– We know how the items are made and finished
– We know the creator and builder of the products
– We know the materials used in the furniture, lighting and accessories
– We know the products are environmentally sustainable

The SwitzerCultCreative goal is to provide home furnishing products that help people create personal environments that provide peace, tranquility and positive energy – while ensuring high-quality products that are eco-conscious.

About Jay Miron Furniture: I design and build bespoke furniture in Vancouver, Canada. Designing and building furniture is more than a job or a career to me. It’s a way of life. I’m constantly exploring new ideas and taking inspiration from everything around me. I love the creativity of designing, the physicality of working the wood by hand, and the challenge of merging the two to make a functional and beautiful piece. High-level woodworking takes discipline. The skills must be learned from a master and constantly worked at to improve. You can often follow the line of teachers back several generations. I am grateful to have received my training under Robert VanNorman, learning the Krenovian style of woodworking at his Inside Passage School of Fine Cabinetmaking. Robert learned this style from the legendary James Krenov, who himself studied under the great Carl Malmsten. I am proud of the knowledge I have received, passed down from these great masters, and work hard every day to further and continue their legacy. I have a huge appreciation for wood and the trees that supply it. Trees are one of the earth’s most important natural resources; they provide the air we breathe, clean our air and water, provide habitat for countless animal species, prevent soil erosion, provide food, cool us with shade, and generally make our world a more beautiful place. Because my craft is founded in this invaluable resource I feel a huge responsibility to do the very best work I can in a sustainable fashion.

On top of my technical training as a furniture maker, I’m currently working toward an education in Interior Design. This has been advantageous in helping me work with clients, architects, and designers to place my furniture within an overall concept of a space.